FDA Approves Roche Breast Cancer Drug
16:49 EDT 8 Jun 2012 | Wall Street Journal
The FDA approved a new drug to treat women with advanced cases of a specific type of breast cancer. Perjeta, was developed by Roche Holding's Genentech unit to treat women whose breast cancer tests positive for protein called HER2 and has spread bey..
Original Article: FDA Approves Roche Breast Cancer Drug
More From BioPortfolio on "FDA Approves Roche Breast Cancer Drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
